Crossmark

Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?

Crossref DOI link: https://doi.org/10.1186/s12974-014-0198-z

Published Online: 2014-12-05

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Loeffler, David A
License Information

License valid from 2014-12-01